N-(4-Biphenylmethyl)imidazoles as Potential Therapeutics for the Treatment of Prostate Cancer: Metabolic Robustness Due to Fluorine Substitution?
Journal article published in 2003 by
Frédéric Leroux 
,
Tilman U. Hutschenreuter,
Céline Charrière,
Rosario Scopelliti,
Rolf W. Hartmann
,
Tilman U. Hutschenreuter,
Céline Charrière,
Rosario Scopelliti,
Rolf W. Hartmann
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 